ProCE Banner Activity

Könnten Virostatika bei der Prophylaxe oder Behandlung von Long COVID eine Rolle spielen?

Clinical Thought
Dr. Cristina Mussini erörtert, ob sich antivirale COVID-19-Medikamente bei der Prophylaxe und/oder Behandlung von Long COVID als nützlich erweisen, von Clinical Care Options (CCO)

Released: December 05, 2022

Share

Faculty

Cristina Mussini

Cristina Mussini, MD

Head of Department of Infectious Diseases and Tropical Medicine
Full Professor of Infectious Diseases

Infectious Diseases Clinics, University Hospital
University of Modena and Reggio Emilia
Modena, Italy

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Pfizer, Inc.

Faculty Disclosure

Primary Author

Cristina Mussini, MD

Head of Department of Infectious Diseases and Tropical Medicine
Full Professor of Infectious Diseases

Infectious Diseases Clinics, University Hospital
University of Modena and Reggio Emilia
Modena, Italy

Dr. Cristina Mussini: Consultant/Beraterin/Sprecherin:: AbbVie, Angelini, Gilead Sciences, Janssen, MSD, Pfizer, Roche, ViiV Healthcare; Forscherin: Gilead Sciences, Janssen, MSD, ViiV Healthcare.